Tay-Sachs Disease Treatment Market - Top Companies and Manufacturers

  • Report ID: 3092
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Companies Dominating the Tay-Sachs Disease Treatment Landscape

    There is no known cure for Tay-Sachs disease, but treatment is given for the symptoms, which can be different for different patients, and stages. The treatment approach can range from physical therapy, chest physiotherapy, and respiratory care, to antipsychotic medications, and other treatment methods. The major tay-sachs disease treatment market players manufacturing the various kind of drugs needed to treat the symptoms include

    • Sio Gene Therapies Ltd.,
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • F. Hoffmann-La Roche Ltd,
    • Pfizer Inc.,
    • Bayer AG,
    • Bausch Health Companies Inc.,
    • Boehringer Ingelheim International GmbH,
    • AbbVie Inc.,
    • Amgen Inc.,
    • Novartis AG
    • Progenity, Inc.

Browse Key Market Insights with Data Illustration:

In the News

· September 9, 2020: Bayer AG to collaborate with Recursion Pharmaceuticals, Inc., to step into research and drug discovery.


Author Credits:  Radhika Pawar


  • Report ID: 3092
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of tay-sachs disease treatment is estimated at USD 2.39 billion.

Tay-Sachs Disease Treatment Market size was over USD 2.29 billion in 2023 and is anticipated to reach USD 4.71 billion by 2036, witnessing around 5.7% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of the genetic disease in specific communities, and growing R&D investment for medical research will impel the market growth.

North America is likely to hold largest revenue share by 2036, on the back of growing cases of Tay-Sachs disease in the region.

The major players in the market are Sio Gene Therapies Ltd, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Amgen Inc. and others who manufacture drugs to treat the symptoms of Tay-Sachs disease.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample